Inside Washington: Crisis and Costs Grip Biotech Industry

October 15, 2001
Jill Wechsler
Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

Volume 14, Issue 10

by Jill Wechsler Terrorist attack may postpone health policy legislation but encourage antibioterrorism initiatives.